Krystal Biotech (KRYS) has received a new Buy rating, initiated by William Blair analyst, Sami Corwin. Sami Corwin has given his Buy rating due ...

Chardan Capital analyst Geulah Livshits has reiterated their bullish stance on KRYS stock, giving a Buy rating yesterday. Geulah Livshits has ...